ID: ALA191751

Max Phase: Preclinical

Molecular Formula: C37H38N4O6

Molecular Weight: 634.73

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  N[C@@H](Cc1ccc(O)cc1)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

Standard InChI:  InChI=1S/C37H38N4O6/c38-30(19-26-15-17-29(42)18-16-26)36(45)41-23-28-14-8-7-13-27(28)22-33(41)35(44)39-31(20-24-9-3-1-4-10-24)34(43)40-32(37(46)47)21-25-11-5-2-6-12-25/h1-18,30-33,42H,19-23,38H2,(H,39,44)(H,40,43)(H,46,47)/t30-,31-,32-,33-/m0/s1

Standard InChI Key:  JYOUATXRHWNDDW-YRCZKMHPSA-N

Associated Targets(Human)

Delta opioid receptor 15096 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 19785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mu opioid receptor 6060 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Kappa opioid receptor 4577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cavia porcellus 23802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Delta opioid receptor 3127 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Delta opioid receptor 3911 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Opioid receptors; mu & delta 878 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 3620 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

mu/kappa opioid receptor 15 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 634.73Molecular Weight (Monoisotopic): 634.2791AlogP: 2.76#Rotatable Bonds: 12
Polar Surface Area: 162.06Molecular Species: ACIDHBA: 6HBD: 5
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.83CX Basic pKa: 7.72CX LogP: 1.84CX LogD: 1.69
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.16Np Likeness Score: -0.08

References

1. Schiller PW, Weltrowska G, Nguyen TM, Wilkes BC, Chung NN, Lemieux C..  (1993)  TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.,  36  (21): [PMID:8230106] [10.1021/jm00073a020]
2. Schiller PW, Weltrowska G, Nguyen TM, Wilkes BC, Chung NN, Lemieux C..  (1993)  TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.,  36  (21): [PMID:8230106] [10.1021/jm00073a020]
3. Kumar V, Murray TF, Aldrich JV..  (2002)  Solid phase synthesis and evaluation of Tyr-Tic-Phe-Phe(p-NHCOCH(2)Br) ([Phe(p-bromoacetamide)(4)]TIPP), a potent affinity label for delta opioid receptors.,  45  (18): [PMID:12190304] [10.1021/jm020290p]
4. Maeda DY, Berman F, Murray TF, Aldrich JV..  (2000)  Synthesis and evaluation of isothiocyanate-containing derivatives of the delta-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for delta-opioid receptors.,  43  (26): [PMID:11150176] [10.1021/jm000345s]
5. Kumar V, Murray TF, Aldrich JV..  (2000)  Extended TIP(P) analogues as precursors for labeled delta-opioid receptor ligands.,  43  (26): [PMID:11150177] [10.1021/jm000362h]
6. Tourwé D, Mannekens E, Diem TN, Verheyden P, Jaspers H, Tóth G, Péter A, Kertész I, Török G, Chung NN, Schiller PW..  (1998)  Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.,  41  (26): [PMID:9857087] [10.1021/jm981011u]
7. Tourwé D, Mannekens E, Diem TN, Verheyden P, Jaspers H, Tóth G, Péter A, Kertész I, Török G, Chung NN, Schiller PW..  (1998)  Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.,  41  (26): [PMID:9857087] [10.1021/jm981011u]
8. Van den Eynde I, Laus G, Schiller PW, Kosson P, Chung NN, Lipkowski AW, Tourwé D..  (2005)  A new structural motif for mu-opioid antagonists.,  48  (10): [PMID:15887972] [10.1021/jm0491795]
9. Tóth G, Ioja E, Tömböly C, Ballet S, Tourwé D, Péter A, Martinek T, Chung NN, Schiller PW, Benyhe S, Borsodi A..  (2007)  Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.,  50  (2): [PMID:17228874] [10.1021/jm060721u]
10. Balboni G, Trapella C, Sasaki Y, Ambo A, Marczak ED, Lazarus LH, Salvadori S..  (2009)  Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore.,  52  (17): [PMID:19642675] [10.1021/jm900686q]
11. Berezowska I, Chung NN, Lemieux C, Wilkes BC, Schiller PW..  (2009)  Agonist vs antagonist behavior of delta opioid peptides containing novel phenylalanine analogues in place of Tyr(1).,  52  (21): [PMID:19827750] [10.1021/jm9004913]
12. Berezowska I, Lemieux C, Chung NN, Ding J, Schiller PW..  (2012)  Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at the δ opioid receptor. Discovery of two highly potent and selective δ opioid agonists.,  22  (5): [PMID:22325949] [10.1016/j.bmcl.2012.01.063]
13. Weltrowska G, Nguyen TM, Chung NN, Wilkes BC, Schiller PW..  (2013)  N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.,  23  (18): [PMID:23932788] [10.1016/j.bmcl.2013.07.036]

Source